EU Medical Device Cybersecurity: Navigating MDCG 2019-16 Under MDR & IVDR

This episode delves into the critical requirements for medical device cybersecurity in the European Union. We explore the concept of "state of the art" as defined by the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), focusing on the key guidance document, MDCG 2019-16 Rev. 1. Learn how this guidance impacts your design controls, risk management, post-market surveillance, and change management processes to avoid common and costly audit nonconformities. - What does "state of the art" mean for medical device cybersecurity in the EU? - Why is MDCG 2019-16 Rev. 1 a critical document for your technical file? - How do you integrate "secure by design" principles into your product lifecycle? - Are your post-market surveillance activities adequately addressing cybersecurity vulnerabilities? - When does a cybersecurity patch trigger a significant change notification to your Notified Body? - What are the most common cybersecurity-related nonconformities in MDR and IVDR audits? - How does vulnerability handling connect to your vigilance reporting obligations? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies. We develop efficient regulatory strategies and use advanced AI to compile and submit technical dossiers, ensuring compliance with complex requirements like cybersecurity. Our experts provide continuous regulatory monitoring to keep you ahead of changes that impact your market access. With a presence in over 30 markets, we act as your local representative, managing post-market surveillance and ensuring ongoing compliance. Let us help you navigate the global landscape. Contact us at [email protected], visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.